Clinical Research Associates Llc

EIN 463285474

New York, NY 10017 |(646) 654-0066

Total Given 2017–2024
$1.9M
20 grants · $235K avg/year
based on 8 yrs of IRS 990-PF records on file
$100K+/yr
local funder
capacity
$76K
typical mid grants · $56K–$131K
grant size
50%
supporter · 6/12 multi-year
repeat
$1.4M
Assets (2024)
12
Distinct Recipients

Focus Areas

Health Human Services

Application Information

Accepts Unsolicited Proposals No — Preselected Only
Phone (646) 654-0066

Financial Trends

Giving Over Time

Total Assets Over Time

View financial data as table
YearTotal GivingTotal AssetsRevenueGrants
2017 $1.1M $1.0M $2.1M 12
2018 $282K $1.2M $1.7M 4
2019 N/A $1.4M $3.2M N/A
2020 $232K $669K $1.4M 2
2021 $45K $606K $1.6M 1
2022 N/A $2.3M $3.2M N/A
2023 N/A $1.4M $3.1M N/A
2024 $200K $1.4M $4.2M 1

Grant Size Distribution

Based on 20 grants on record

Minimum
$18K
25th Pctl
$56K
Median
$76K
Average
$94K
75th Pctl
$131K
Maximum
$230K

Geographic Distribution

US Grant Distribution Map

Officers & Directors

DS
David Spergel 4 yrs
Chairperson/Manager Leadership
KM
Kelsey Martin 4 yrs
President/Manager Leadership
ER
Euan Robertson 4 yrs
Vice President Leadership
MK
Marlow Kee 8+ yrs
Treasurer/Manager Leadership
BD
Brett Dakin 2 yrs
Secretary Leadership

Grants Awarded (20 total)

Purpose
Massachusetts Institute of Technology Cambridge, MA $230,259 Advancing a Biomarker of Reduced GABAergic Action in the Autistic Brain 2017
The Children'S Hospital of Philadelphia Research Institute Philadelphia, PA $200,000 COMPUTER VISION BASED PHENOTYPING OF 16P11.2 ARBACLOFEN DOUBLE BLIND PLACEBO CONTROLLED STUDY. 2024
The Childrens Hospital of Philadelphia Philadelphia, PA $149,808 MEG/MRS Dose Response Study of STX209 in ASD 2017
The Children'S Hospital of Philadelphia Philadelphia, PA $149,808 MEG/MRS Dose Response Study of STX209 in ASD 2017
The Childrens Hospital of Philadelphia Philadelphia, PA $149,808 MEG/MRS Dose Response Study of STX209 in ASD 2018
University of Washington Seattle, WA $124,722 ELECTROPHYSIOLOGICAL INDICES OF NEURAL FUNCTION ASSOC. WITH ARBACLOFEN ADMIN. IN 16P11.2 2020
The Children'S Hospital of Philadelphia Research Institute Philadelphia, PA $107,775 COMPUTER VISION BASED PHENOTYPING OF 16P11.2 ARBACLOFEN DOUBLE BLIND PLACEBO CONTROLLED STUDY. 2020
The Regents of the University of California Davis, CA $87,646 Preclinical evaluation of therapeutic efficacy of r-baclofen in reversing behavioral deficits in 16p11.2 deletion mice 2017
The Trustees of the University of Pennsylvania Philadelphia, PA $85,946 Assessment of Arbaclofen treatment on habituation, cognition and repetitive motor behaviors in a mouse model of 16p... 2017
Institut De Genetique Et De Biologie Moleculaire Illkirch, None $77,741 R-Baclo2: Retesting the Arbaclofen treatment on the Del(7Sult1a1-Spn)6Yah 16p11.2 deletion model 2017
King'S College London London, None $75,001 GABAb in ASD. A high dose Arbaclofen fMRI and visual processing study. 2017
King'S College London London, None $74,999 GABAb in ASD. A high dose Arbaclofen fMRI and visual processing study. 2017
King'S College London London, None $74,999 GABAb in ASD. A high dose Arbaclofen fMRI and visual processing study. 2018
John Hopkins University School of Medicine Baltimore, MD $74,154 Development of radiotracers for PET imaging of GABA-B receptors in non-human primates 2017
Harvard Medical School Boston, MA $59,875 Using Motion Sequencing to Assess Behavioral Effects of Arbaclofen 2017
University of Washington Seattle, WA $44,758 ELECTROPHYSIOLOGICAL INDICES OF NEURAL FUNCTION ASSOC. WITH ARBACLOFEN ADMIN. IN 16P11.2 2021
Masachusetts Institute of Technology Cambridge, MA $39,084 Advancing a Biomarker of Reduced GABAergic Action in the Autistic Brain 2017
Massachusetts Institute of Technology Cambridge, MA $39,084 Advancing a Biomarker of Reduced GABAergic Action in the Autistic Brain 2018
Institut De Genetique Et De Biologie Moleculaire Illkirch, None $18,317 R-Baclo2: Retesting the Arbaclofen treatment on the Del(7Sult1a1-Spn)6Yah 16p11.2 deletion model 2017
Institut De Genetique Et De Biologie Moleculaire Illkirch, None $18,317 R-Baclo2: Retesting the Arbaclofen treatment on the Del(7Sult1a1-Spn)6Yah 16p11.2 deletion model 2018